Can an AI Doctor's helper save lives from heart failure?
NCT ID NCT07380555
Summary
This study is testing whether an artificial intelligence (AI) system can help doctors choose the best medications for people with a specific type of heart failure. About 1,200 patients from 60 hospitals will participate. The main goal is to see if AI-guided care leads to fewer hospitalizations and deaths compared to the standard way doctors currently manage treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HF-REF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Zhongshan Hospital
Shanghai, Shanghai Municipality, 200032, China
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.